RecruitingNot ApplicableNCT06590805

Electroacupoint for Diminutive Milk Production

Ameliorative Potential of Electroacupoint for Diminutive Milk Production in Lactating Woman


Sponsor

Haytham Ibrahim Morsi

Enrollment

36 participants

Start Date

Sep 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study was to reveal the effect of electroacupoint on scanty milk production in lactating women.


Eligibility

Sex: FEMALEMin Age: 25 YearsMax Age: 30 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Balanced Diet using domperidone drug, iron, and folic acid supplementation. and a procedure called Electrotherapy using Chattanooga stimulation unit for people with dietary modification, electrotherapy, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 25 Years to 30 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREElectrotherapy using Chattanooga stimulation unit

Electroacupoint stimulation using the Chattanooga intellect transport 2-channel electrotherapy stimulation unit 2783. It uses the influences energy flows by needling the acupuncture points which lie along the body meridians to achieve a harmonious balance between physical, emotional, and spiritual states. The same effect can be achieved without the use of needles. These needleless stimulations are noninvasive and nontraumatic and are useful for individuals who are scared of needles. They are also associated with decreased risk of infection or bruise.

DIETARY_SUPPLEMENTBalanced Diet using domperidone drug, iron, and folic acid supplementation.

Postnatal care diet in form of balanced diet using domperidone drug, iron, and folic acid supplementation. Additionally, drinking sufficient clean water and routine postnatal care. It was performed by asking the participant to take ten mg domperidone three times a day after meals. Iron and folic acid supplementation were also continue for three months after birth.


Locations(1)

Kafrelsheikh University

Kafrelsheikh, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06590805


Related Trials